We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WDFC:NASDAQWD-40 Company Analysis

Data as of 2026-09-15 - not real-time

$191.01

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind WD-40 Company is neutral at $191.01, with no clear ordering between short and long averages. It has lost 16.0% over the past 30 days. RSI sits at 20.6, which reads as oversold, and MACD momentum is bearish. Recent trading has carved out support near $190.00 and resistance around $232.81.
The shares look fair at 29.0 times earnings, though no sector average was available for comparison. Sell-side targets cluster 42.2% above the current quote. Revenue is growing at 24.3% on a 13.2% profit margin. The 2.13% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 26.1%, a beta of 0.17 and a maximum drawdown of 27.9%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

Household products company WD-40 NASDAQ:WDFC in Q2 CY2026, with sales up 24.Looking back on household products stocks’ Q2 earnings, we examine this quarter’s best and worst performers,...Shares of household products company WD-40 NASDAQ:WDFC jumped 9% in the afternoon session after it reported...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 20.6 signals oversold conditions
  • Trading below the 200-day average of 218.69
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 20.6 signals oversold conditions
  • Trading below the 200-day average of 218.69
  • Analyst targets imply +42.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +42.2% versus the current price
  • Revenue growth of +24.3%
  • P/E ratio of 29.0

Key Metrics & Analysis

Financial Health

Revenue Growth24.30%
Profit Margin13.23%
P/E Ratio29.0
ROE33.31%
ROA15.42%
Debt/Equity41.05
P/B Ratio9.2
Op. Cash Flow$84.8M
Free Cash Flow$68.6M

Technical Analysis

TrendNeutral
RSI20.6
Support$190.00
Resistance$232.81
MA 20$210.00
MA 50$226.50
MA 200$218.69
MACDBearish
VolumeIncreasing
Fear & Greed Index90.3

Valuation

Fair Value$163.03
Target Price$271.67
Upside/Downside42.23%
GradeFair
TypeGrowth
Dividend Yield2.13%

Risk Assessment

Beta0.17
Volatility26.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.